Optimizing therapy for mild to moderate IBD

Описание к видео Optimizing therapy for mild to moderate IBD

Earn CME for related activities: https://www.naccme.com/gastro

In this presentation from the 2018 Mastering Clinical Challenges and Emerging Therapies in IBD conference, Dr. Stephen B. Hanauer discusses best practices for optimizing therapy for mild-to-moderate inflammatory bowel disease (IBD), with a focus on the foundational therapeutic agents, 5-ASA, corticosteroids, and immunomodulators.

© 2018 Imedex, LLC.

Комментарии

Информация по комментариям в разработке